Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Binding affinity of compound in competition with [125I]- CGP-23996 in somatostatin receptor binding to rat brain membrane; Not determined
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Compound was tested for in vitro SRIF inhibition of GH release in rats
Assay data:21 Active, 18 Activity ≤ 1 µM, 26 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
SRIF inhibition of GH release in rats
Assay data:17 Tested
Antagonism of in vitro SRIF inhibition of GH release from rat pituitary cells in culture
Assay data:8 Active, 1 Activity ≤ 1 nM, 8 Activity ≤ 1 µM, 8 Tested
Antagonism of in vitro SRIF inhibition of GH release from rat pituitary cells in culture; not determined
Assay data:10 Tested
Antagonism of in vitro SRIF inhibition of GH release from rat pituitary cells in culture; not determined; not determined
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Ability to inhibit binding of [3I]-CGP 23996 to somatostatin receptor on membranes from cerebral cortex
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Ability to inhibit binding of [3I]-CGP 23996 to somatostatin receptor on membranes from pituitary
Antagonism of in vitro SRIF inhibition of GH release in rat in vitro pituitary cell assay
Assay data:42 Active, 39 Activity ≤ 1 µM, 44 Tested
Binding affinity in competition with [125I]- CGP-23996 in somatostatin receptor binding to rat brain membrane
Assay data:12 Active, 1 Activity ≤ 1 µM, 20 Tested
Rat SST3 receptor (Somatostatin receptors)
Assay data:11 Active, 11 Tested
Compound was tested for its inhibitory effect against somatostatin receptor in rat cortex membrane using [125I]Tyr3-octreotide as the radioligand
Assay data:3 Active, 2 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Compound was tested for its potency to displace 3-[125I]- - Tyr11-SRIF-14 from somatostatin receptor on membranes of rat cerebral cortex
Assay data:2 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 7 Tested
Radioligand binding studies on rat cortex membranes using 125 I-Tyrs-octreotide as ligand was determined
SummaryRelated BioAssays by Target
SummaryCompounds, ActiveRelated BioAssays by Target
Inhibitory activity against Somatostatin receptor in rat cortex membrane using 125 I-Tyrs-octreotide as radioligand
The displacement of [64Cu]-TETA-OC by the compound on rat CA20948 pancreatic tumor cell membranes
Assay data:4 Active, 4 Activity ≤ 1 nM, 4 Activity ≤ 1 µM, 4 Tested
In vitro binding affinity of [111In]DTPA-[Y3]-octreotate to somatostatin receptor in the rat pancreatic tumor cell line, CA20498
Assay data:14 Active, 2 Activity ≤ 1 nM, 15 Activity ≤ 1 µM, 15 Tested
Displacement of [125I]SRIF-14 from SSTR of rat AR42J cell membranes
Assay data:5 Active, 3 Activity ≤ 1 nM, 5 Activity ≤ 1 µM, 5 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on